

THE
SCIENCE OF
POSSIBILITY
SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
News
Vertex announces fourth quarter and full year 2022 financial results
FDA clears Vertex’s Investigational New Drug (IND) application for our mRNA therapy for cystic fibrosis
Vertex to present at the American Society of Hematology (ASH) Annual Meeting
Vertex partners with U.S. basketball Hall-of-Famer Alonzo Mourning to raise awareness of APOL1-mediated kidney disease (AMKD)
Working at Vertex
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.

Featured Stories